Advocates call for universal testing for lung cancer mutation

Cancer advocates say lives are being cut short needlessly because there's no universal testing for a type of lung cancer mutation.
About 8 percent of advanced lung cancer patients have the mutation, and oncologists say drugs available from December can help those people live up to five years longer.
But most district health boards aren't testing for it.
Meriana Johnsen reports.